When was ZYUS Life Sciences founded?

ZYUS Life Sciences was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is ZYUS Life Sciences located?

ZYUS Life Sciences is headquartered in Saskatoon, Canada.

Who is the current CEO of ZYUS Life Sciences?

Brent Zettl of ZYUS Life Sciences. They have also founded 1 company.

How many employees does ZYUS Life Sciences have?

As of Aug 31, 2026, the latest employee count at ZYUS Life Sciences is 53.

Is ZYUS Life Sciences a funded company?

ZYUS Life Sciences is a funded company, having raised a total of $19.5M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 20, 2019.

When was the latest funding round of ZYUS Life Sciences?

ZYUS Life Sciences' latest funding was a $***** Post IPO round on Mar 20, 2026, with participation from 0 investor.

Where does ZYUS Life Sciences rank among its competitors?

ZYUS Life Sciences ranks 3rd amongst 240 active competitors, of which 27 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Terraflos, which secured $3.5M in Jun, 2026.

Who are the top competitors of ZYUS Life Sciences?

ZYUS Life Sciences' top competitors include Sanity Group, Terraflos and gLeaf. Among them, Terraflos secured the most recent funding round in June, 2026.

ZYUS Life Sciences - 2026 Company Profile, Team, Funding & Competitors

ZYUS Life Sciences is a public company based in Saskatoon (Canada), founded in 2018 by Brent Zettl. It operates as a Developer of cannabis-derived therapeutics for multiple indications. ZYUS Life Sciences has raised $19.5M in funding. The company has 240 active competitors, including 27 funded and 56 that have exited. Its top competitors include companies like Sanity Group, Terraflos and gLeaf.

Company Details

Developer of cannabis-derived therapeutics for multiple indications. The company is focusing on the development of cannabinoid-based therapeutics and protein-based formulations to provide targeted relief for patients. The company's lead drug candidate is Trichomylin to alleviate chronic pain.

Website: www.zyus.com
Social
Email ID: *****@zyus.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Saskatoon, Canada

Stage

Public

Total Funding

$19.5M in 9 rounds

Latest Funding Round

Post IPO, Mar 20, 2026, $*****

Investors

Keyhorse Capital & 1 more

Ranked

3^rd among 240 active competitors

Employee Count

53 as on Aug 31, 2026

Investment & Acquisitions

Revon Systems

Similar Companies

Sanity Group & 291 more

Exit Details

Public

View ZYUS Life Sciences' full profile

ZYUS Life Sciences got listed on Jun 23, 2023.

Click here to take a look at ZYUS Life Sciences's IPO in detail

ZYUS Life Sciences has raised a total funding of $19.5M over 9 rounds. Its first funding round was on May 20, 2019. ZYUS Life Sciences has 2 institutional investors.

Here is the list of recent funding rounds of ZYUS Life Sciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 20, 2026	5052127	Post IPO	7140997	8086103	8696770	1248620
Nov 07, 2025	4634378	Post IPO	7393910	1240556	1409444	7316357
Jul 29, 2025	7720466	Post IPO	6243461	4702146	3755905	5933492

Access funding benchmarks and valuations. Sign up today!

View details of ZYUS Life Sciences's funding rounds and investors

The founders of ZYUS Life Sciences is Brent Zettl. Brent Zettl is the CEO of ZYUS Life Sciences.

Here are the details of ZYUS Life Sciences' key team members:

Brent Zettl: Founder & CEO of ZYUS Life Sciences.
Contact Info: 1 email address

View details of ZYUS Life Sciences's Founder profiles and Board Members

ZYUS Life Sciences' employee count trend

ZYUS Life Sciences has 53 employees as of Aug 26. Here is ZYUS Life Sciences's employee count trend over the years:

Employee count trend for ZYUS Life Sciences

Uncover ZYUS Life Sciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ZYUS Life Sciences include Sanity Group, Terraflos and gLeaf. Here is the list of Top 10 competitors of ZYUS Life Sciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sanity Group 2011, Berlin (Germany), Acquired	Developer of cannabinoid-based pharmaceuticals and well-being products	$109M	HV Capital, TQ Ventures & 18 others	67/100
2nd	Terraflos 2021, Uruguay, Seed	Provider of cannabis medical products	$11.5M	Rainforest Capital, YaaX Capital & 4 others	59/100
3rd	ZYUS Life Sciences 2018, Saskatoon (Canada), Public	Developer of cannabis-derived therapeutics for multiple indications	$19.5M	Keyhorse Capital, Mammoth View	58/100
4th	gLeaf 2014, Frederick (United States), Acquired	Medical cannabis cultivator	$19.4M	Chicago Atlantic	56/100
5th	BOHECO 2013, Mumbai (India), Seed	Provider of cannabis-derived nutritional and wellness products	$9.95M	Absolem Technologies, S R B Buildtech LLP ... & 34 others	56/100
6th	Avicanna 2016, Toronto (Canada), Public	Developer of plant-derived cannabinoid-based products	$5.94M	Orthogonal Thinker, Barn Invest & 1 others	52/100
7th	IMCannabis 2008, Herzliya (Israel), Public	Developer of medical cannabis products	-	-	51/100
8th	Creso Pharma 2015, Perth (Australia), Acquired	Developer of cannabinoid therapeutics for multiple health purposes	-	EverBlu Capital, L1 Capital	51/100
9th	Little Green Pharma 2016, Perth (Australia), Public	Manufacturer of medicinal cannabis for therapeutic use	$1.91M	Fastforward Innovations	49/100
10th	Grow Group 2017, London (United Kingdom), Series C	Developer of cannabis-based medicines for multiple indications	$12.6M	-	46/100